Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.600
-0.080 (-4.76%)
At close: Aug 13, 2025, 4:00 PM
1.589
-0.011 (-0.70%)
After-hours: Aug 13, 2025, 7:15 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $98.22 million as of August 13, 2025. Its market cap has decreased by -87.82% in one year.
Market Cap
98.22M
Enterprise Value
-99.36M
1-Year Change
-87.82%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $98.22M, a decrease of -86.68%. That is a compound annual growth rate of -32.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 103.13M | -87.13% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |